Close X
Sunday, September 22, 2024
ADVT 
National

Spending tied to COVID-19 set to drop sharply: PBO

Darpan News Desk The Canadian Press, 10 Mar, 2021 05:52 PM
  • Spending tied to COVID-19 set to drop sharply: PBO

Parliament's budget watchdog says the portion of federal spending related to COVID-19 is set to drop by 86 per cent in the coming fiscal year compared to 2020-21, as Canada transitions away from emergency pandemic measures.

The government is planning $22.7 billion in COVID-19-related spending over the coming year, versus an estimated $159.5 billion to date, according to a new report from parliamentary budget officer Yves Giroux.

Part of the decline relates to a projected plunge in relief spending for individuals.

In 2020-21, an estimated $122 billion flowed to Canadians via labour market supports such as the emergency response benefit, the recovery benefit and enhanced employment insurance, the report states.

The comparable figure for 2021-22 is less than $43 billion, reflecting a gradual phaseout of aid measures.

The report is based on estimates tabled in Parliament last month and does not factor in the coming budget, which may not be introduced until April.

Of the $342.2 billion outlined in the 2021-22 estimates, roughly one in every five dollars is earmarked for monthly payments to Canadian seniors, amounting to $62.4 billion in elder benefits. The benefits are indexed to inflation.

The Canada Health Transfer, indexed to GDP growth, comprises the second-largest component of federal spending, amounting to $43.1 billion to help provinces and territories to help pay for health care.

Parliament must approve government spending through a process called the estimates, with the main estimates — brought forward on Feb. 27 — providing base funding for all departments.

The estimates show the Finance Department budget is slated to shrink by 13 per cent to $103.8 billion and the budget for Employment and Social Development Canada by more than half to $82.4 billion. Public Health Agency of Canada budget is estimated at $8.8 billion, down $21 billion last year.

Of the $342.2 billion outlined in the estimates, $141.9 billion requires House of Commons approval via a pair of appropriation bills.

MORE National ARTICLES

International air travel falling with new rules

International air travel falling with new rules
The drop in international arrivals in early February is about four times the decline seen between early January and early February in 2019 and 2020.

International air travel falling with new rules

Economy fell 5.4 per cent in 2020: StatCan

Economy fell 5.4 per cent in 2020: StatCan
Statistics Canada says real gross domestic product shrank 5.4 per cent in 2020, the steepest annual decline since comparable data was first recorded in 1961.

Economy fell 5.4 per cent in 2020: StatCan

Vancouver home sales up 73% year-over-year: REBGV

Vancouver home sales up 73% year-over-year: REBGV
"The supply of listings for sale isn’t keeping up with the demand we’re seeing,” said Colette Gerber, REBGV's chair, in a release.

Vancouver home sales up 73% year-over-year: REBGV

Churches challenge B.C. COVID-19 health orders

Churches challenge B.C. COVID-19 health orders
Henry and the province have said they are confident the health orders are in accordance with the law, including the Charter of Rights and Freedoms.

Churches challenge B.C. COVID-19 health orders

1478 COVID19 cases over 3 days

1478 COVID19 cases over 3 days
With the additional supply from the newly approved AstraZeneca/Serum Institute of India viral vector vaccine, combined with setting the second dose interval at 16 weeks, everyone moves up the line, meaning more people will be vaccinated more quickly.

1478 COVID19 cases over 3 days

AstraZeneca's vaccine not for seniors: NACI

AstraZeneca's vaccine not for seniors: NACI
The AstraZeneca vaccine was authorized for use Friday on all adults, including seniors, but the National Advisory Committee on Immunization is concerned there is limited data on how well the vaccine will work in older populations.

AstraZeneca's vaccine not for seniors: NACI